This article examines whether dynamic factor allocation can reliably improve on a simple strategic allocation across established equity factors. Using a broad set of timing approaches, including factor momentum, volatility scaling, seasonal patterns, investor sentiment, performance decay, and combinations of signals, the analysis shows that statistically significant backtest results do not necessarily constitute evidence of successful factor timing. Apparent timing profits may instead reflect persistent strategic factor tilts, exposure to established return sources, changes in total factor risk, leverage, or sample-specific optimization. The results also demonstrate that implementation choices, trading delays, turnover, transaction costs, and the real-time availability of information can materially reduce apparent performance. Combining timing signals offers diversification benefits, but optimizing their weights introduces additional estimation error and the potential for overfitting. More generally, performance decay should not automatically be interpreted as a signal to reduce factor exposure. The evidence supports evaluating dynamic factor allocation within a portfolio construction framework that begins with a clearly specified strategic factor portfolio and then asks whether departures from that benchmark are economically motivated, distinct from existing factor exposures, implementable, and robust. Dynamic factor allocation may add value, but it should face a higher burden of proof than strategic factor diversification.
No takes yet. Share an insight, caveat, or question.
Blitz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: